NCT02809040

Brief Summary

Hypertensive heart disease (HHD) is a heart condition that is caused by chronic exposure to high blood pressure. In patients with HHD, abnormalities in the way heart muscle relaxes and how heart chambers passively fill with blood (diastolic dysfunction) can occur that may be detected on echocardiography (echo), which is a standard clinical method to examine heart structure and function using reflected sound waves. Investigators propose to develop a digital auscultation system or electronic stethoscope based on wireless sensor node technique. Investigators hypothesize that the heart sounds measurements detected by electronic stethoscope can be used to detect heart diastolic dysfunction in HHD .

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2015

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2015

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

May 31, 2016

Completed
22 days until next milestone

First Posted

Study publicly available on registry

June 22, 2016

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2018

Completed
Last Updated

July 14, 2017

Status Verified

July 1, 2017

Enrollment Period

3.2 years

First QC Date

May 31, 2016

Last Update Submit

July 11, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Heart sound measurement from proposed device will be correlated with diastolic functional parameters from echo result and cardiac catheterization.

    Heart sound measurement will be correlated with End diastolic pressure from cardiac catheterisation.

    Through study completion (October 2016)

Study Arms (3)

Hypertensive Heart Disease

Portable Digital Auscultation/ Electrocardiogram/Echocardiography/ Traditional Stethoscope

Other: Electrocardiogram/EchocardiographyOther: Portable digital auscultation

Volunteer subjects

Portable Digital Auscultation/ Electrocardiogram/Echocardiography/ Traditional Stethoscope

Other: Electrocardiogram/EchocardiographyOther: Portable digital auscultation

Diagnosed Hypertension

Portable Digital Auscultation/ Electrocardiogram/Echocardiography/ Traditional Stethoscope

Other: Electrocardiogram/EchocardiographyOther: Portable digital auscultation

Interventions

Electrocardiogram (ECG) is a non-invasive (does not require an incision into the body) test that records the electrical activity of the heart. Echocardiography is a non-invasive scanning of heart images using standard two-dimensional, three-dimensional, and Doppler ultrasound to create images of the heart.

Diagnosed HypertensionHypertensive Heart DiseaseVolunteer subjects

Traditional Stethoscope :An acoustic medical device for auscultation, or listening to internal sounds of human body. Digital Stethoscope :Electronic stethoscope is a passive heart sound recording device. The heart sound listening and recording will be performed by trained personnel in a way very similar to that of using conventional cardiac auscultation

Diagnosed HypertensionHypertensive Heart DiseaseVolunteer subjects

Eligibility Criteria

Age21 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will be recruited from primary care clinic and outpatient clinics from the National Heart Centre Singapore.

You may qualify if:

  • Participants with clinically suspected or known HT/Hypertensive Heart Disease who have been scheduled for echocardiography examination and/or cardiac catheterization.
  • Participants with history of high BP and stable medication for at least 2 weeks.
  • Presence of the following :
  • Elevated BP measurement or Left ventricular hypertrophy (LVH) on either prior ECG or prior echo.

You may not qualify if:

  • Participants with heart muscle disease.
  • Participants with significance valve disease.
  • Strictly exclude hypertensive for Normal healthy volunteers.
  • Not on any anti-hypertensive agents.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Heart Centre Singapore

Singapore, 169609, Singapore

Location

Related Publications (9)

  • Whitworth JA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003 Nov;21(11):1983-92. doi: 10.1097/00004872-200311000-00002.

    PMID: 14597836BACKGROUND
  • James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014 Feb 5;311(5):507-20. doi: 10.1001/jama.2013.284427.

    PMID: 24352797BACKGROUND
  • Diamond JA, Phillips RA. Hypertensive heart disease. Hypertens Res. 2005 Mar;28(3):191-202. doi: 10.1291/hypres.28.191.

    PMID: 16097361BACKGROUND
  • Zannad F, Dousset B, Alla F. Treatment of congestive heart failure: interfering the aldosterone-cardiac extracellular matrix relationship. Hypertension. 2001 Nov;38(5):1227-32. doi: 10.1161/hy1101.099484.

    PMID: 11711528BACKGROUND
  • Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990 May 31;322(22):1561-6. doi: 10.1056/NEJM199005313222203.

    PMID: 2139921BACKGROUND
  • Drazner MH, Rame JE, Marino EK, Gottdiener JS, Kitzman DW, Gardin JM, Manolio TA, Dries DL, Siscovick DS. Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study. J Am Coll Cardiol. 2004 Jun 16;43(12):2207-15. doi: 10.1016/j.jacc.2003.11.064.

    PMID: 15193681BACKGROUND
  • Lorell BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation. 2000 Jul 25;102(4):470-9. doi: 10.1161/01.cir.102.4.470. No abstract available.

    PMID: 10908222BACKGROUND
  • Marcus GM, Vessey J, Jordan MV, Huddleston M, McKeown B, Gerber IL, Foster E, Chatterjee K, McCulloch CE, Michaels AD. Relationship between accurate auscultation of a clinically useful third heart sound and level of experience. Arch Intern Med. 2006 Mar 27;166(6):617-22. doi: 10.1001/archinte.166.6.617.

    PMID: 16567599BACKGROUND
  • Shah SJ, Nakamura K, Marcus GM, Gerber IL, McKeown BH, Jordan MV, Huddleston M, Foster E, Michaels AD. Association of the fourth heart sound with increased left ventricular end-diastolic stiffness. J Card Fail. 2008 Jun;14(5):431-6. doi: 10.1016/j.cardfail.2008.01.010. Epub 2008 May 27.

    PMID: 18514937BACKGROUND

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • A/Prof Tan Ru San

    National Heart Centre Singapore

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2016

First Posted

June 22, 2016

Study Start

February 1, 2015

Primary Completion

May 1, 2018

Study Completion

May 1, 2018

Last Updated

July 14, 2017

Record last verified: 2017-07

Data Sharing

IPD Sharing
Will not share

Locations